Experienced in Allergic Conjunctivitis

Dr. David L. Wirta

Ophthalmology | Plastic Surgery
David L Wirta MD Inc
520 Superior Ave, Suite 235, 
Newport Beach, CA 
Experienced in Allergic Conjunctivitis
David L Wirta MD Inc
520 Superior Ave, Suite 235, 
Newport Beach, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Wirta is an Ophthalmologist and a Plastic Surgeon in Newport Beach, California. Dr. Wirta is rated as an Experienced provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Pigment-Dispersion Syndrome, Eyelid Drooping, Dry Eye Syndrome, and Interstitial Keratitis.

His clinical research consists of co-authoring 44 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Allergic Conjunctivitis.

Specialties
Ophthalmology
Plastic Surgery
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

DAVID L WIRTA MD INC
520 Superior Ave, Suite 235, Newport Beach, CA 92663

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drugs: Combination of Mycophenolic Acid and Betamethasone Sodium Phosphate, Mycophenolic Acid, Restasis Ophthalmic Emulsion, Xiidra Ophthalmic Solution
Study Phase: Phase 2
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease (COMET-1)
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease (COMET-1)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Drug
Study Drugs: AR15512, Vehicle
Study Phase: Phase 2
Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Drug
Study Drug: Lotilaner Ophthalmic Solution
Study Phase: Phase 2/Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
Enrollment Status: Completed
Publish Date: August 20, 2020
Intervention Type: Biological
Study Phase: Phase 1
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

44 Total Publications

Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results from a Phase III Controlled Trial.
Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results from a Phase III Controlled Trial.
Journal: Journal of glaucoma
Published: May 28, 2025
Similar Doctors
Distinguished in Allergic Conjunctivitis
Dr. David A. Hollander
Ophthalmology
Distinguished in Allergic Conjunctivitis
Dr. David A. Hollander
Ophthalmology
100 Stein Plaza, Rm 1-340, 
Los Angeles, CA 
 (42.2 miles away)
310-825-3090
Languages Spoken:
English
See accepted insurances

David Hollander is an Ophthalmologist in Los Angeles, California. Dr. Hollander is rated as a Distinguished provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Conjunctivitis (Pink Eye), and Cataract Removal.

Distinguished in Allergic Conjunctivitis
Dr. Sanjay Logani
Ophthalmology
Distinguished in Allergic Conjunctivitis
Dr. Sanjay Logani
Ophthalmology

Advanced Retina Associates Medical Group Inc.

17750 Sherman Way, Suite 100, 
Reseda, CA 
 (52.0 miles away)
818-886-6700
Languages Spoken:
English
See accepted insurances

Sanjay Logani is an Ophthalmologist in Reseda, California. Dr. Logani is rated as a Distinguished provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Blepharitis, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Kallikrein Hypertension.

Distinguished in Allergic Conjunctivitis
Dr. Cuong-dung T. Do
Ophthalmology
Distinguished in Allergic Conjunctivitis
Dr. Cuong-dung T. Do
Ophthalmology
9061 Bolsa Ave, Suite 105, 
Westminster, CA 
 (8.3 miles away)
714-899-5670
Languages Spoken:
English, Vietnamese
See accepted insurances
Accepting New Patients

Cuong-dung Do is an Ophthalmologist in Westminster, California. Dr. Do is rated as a Distinguished provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Glaucoma, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Pterygium. Dr. Do is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wirta's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile